- Previous Close
3.5000 - Open
3.5600 - Bid 3.5000 x --
- Ask 3.6400 x --
- Day's Range
3.5000 - 3.5600 - 52 Week Range
2.4000 - 6.2400 - Volume
11,463 - Avg. Volume
21,608 - Market Cap (intraday)
85.391M - Beta (5Y Monthly) 1.46
- PE Ratio (TTM)
-- - EPS (TTM)
-0.6400 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
8.00
Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden and the Scandinavian market. The company offers oncology, rare diseases, neurology, and other treatment products. Newbury Pharmaceuticals AB (publ) was incorporated in 2020 and is based in Lund, Sweden.
www.newburypharma.com6
Full Time Employees
August 31
Fiscal Year Ends
Sector
Recent News: NEWBRY.ST
View MorePerformance Overview: NEWBRY.ST
Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NEWBRY.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NEWBRY.ST
View MoreValuation Measures
Market Cap
85.39M
Enterprise Value
70.09M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.32
Price/Book (mrq)
1.64
Enterprise Value/Revenue
1.90
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-41.83%
Return on Assets (ttm)
-12.96%
Return on Equity (ttm)
-30.42%
Revenue (ttm)
36.83M
Net Income Avi to Common (ttm)
-15.4M
Diluted EPS (ttm)
-0.6400
Balance Sheet and Cash Flow
Total Cash (mrq)
15.3M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-5.03M